What is the main business of Rattwood?

The main business activity of Rattwood focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 17, 2016.

Where is the headquarters located?

The headquarters is located at: ul. Henryka Wieniawskiego 28, 37-700 Przemyśl.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What revenue was generated?

The company reported a revenue of $133,872 in 2023, which is a decrease of 52.3% compared to 2022.

Is the company profitable?

No, in 2023 the company was not profitable, reporting a net loss of $12,504. For comparison, in 2022 the loss was $9,077, meaning the company increased its loss by 29.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $109,139 in 2023, representing 80% of all operating expenses.

Rattwoodsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-10-17

Share capital

5,000.00 PLN

Registered address

ul. Henryka Wieniawskiego 28, 37-700 Przemyśl, Poland

Electronic delivery address

AE:PL-24730-90919-WIUIR-22

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 62 days for 2021), 1 not filed.

202514/07/2026
2024not filed
202322/07/2024
202228/06/2023
202115/09/2022
202019/07/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.59mMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD 180.39kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 1.40mMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 1.75mMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Anastasiya Khanyk – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Anastasiya Khanykage 29	45	$607.78	45%
Vasyl Yakobage 30	55	$742.84	55%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2016-11-07.

PKO Bank Polski
77 1020 1013 0000 0502 0350 7340
PKO Bank Polski
72 1020 1013 0000 0702 0350 7332
PKO Bank Polski
28 1020 4900 0000 8402 3402 5937

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jul 14, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Przemyśl

Competitors

Name	Revenue	Website
Chde PolskaS.A.	$17,544,214.35	chde.pl
MED Partner Marszałeksp. k.	$5,739,702.56	med-partner.pl
Passimedsp. z o.o.	$1,677,642.39	passimed.pl
Novicaresp. z o.o.	$1,512,398.66	novicare.pl
CryoprofilS.A.	$1,470,469.25	cryoprofil.pl
Pharmbiopolsp. z o.o.	$99,211.10	pharmbiopol.com
Polidental Tradesp. z o.o.	$9,409.06	poli.dental
BIATsp. z o.o.	$2,327.20	biat.pl
Hempire Hempsp. z o.o.	–	hempire.pl
Hempiresp. z o.o.	–	hempire.pl

Change history

Date	Event
2025-10-30	Address change (Ul. Grunwaldzka 13, 37-700, Przemyśl → Ul. Henryka Wieniawskiego 28, 37-700, Przemyśl)
2025-10-16	PKD change (Removed: 46.15.Z, 55, 56; Added: 46.46.Z)
2024-03-19	PKD change (Removed: 93; Added: 62)
2019-09-06	Address change (Ul. Stanisława Kunickiego 5/201, 30-134, Kraków → Ul. Grunwaldzka 13, 37-700, Przemyśl)
2019-09-06	PKD change (Removed: 43; Added: 45)

FAQ

Last updated: 2026-07-17